Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.022 0.7
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.014 0.7
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC -0.027 0.7
mRNA alvocidib CTRPv2 pan-cancer AAC 0.018 0.7
mRNA TAE684 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Vandetanib CCLE pan-cancer AAC -0.017 0.7
mRNA nelarabine CTRPv2 pan-cancer AAC -0.014 0.7
mRNA EX-527 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
Download CSV